Effects of N-n-butyl haloperidol iodide on L-type calcium channels and intracellular free calcium in rat ventricular myocytes. 2007

Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
Department of Pharmacology, Shantou University Medical College, Xinling Road 22, Shantou 515041, China.

The ability of N-n-butyl haloperidol iodide (F2) to cause vasodilation, and thereby produce a cardioprotective effect, has been well documented. The aim of this study was to investigate whether F2 might act as a Ca2+ antagonist. Myocytes were obtained from rat heart, and the whole-cell patch-clamp technique was used to record Ca2+ current. Laser scanning confocal microscopy was used to measure intracellular free calcium ([Ca2+]i). The results obtained from this study demonstrate that F2 reduced calcium current (ICa) in a concentration-dependent manner with an IC50 of 1.19 micromol/L, upshifted the current-voltage curve of ICa, shifted the inactivation kinetics of ICa leftward, and slowed down the recovery of ICa from inactivation. F2 decreased the fluorescent intensity of [Ca2+]i elevation induced by KCl with an IC50 of 1.61 micromol/L, and had no effects on the intracellular calcium release induced by caffeine and inositol-1,4,5-trisphosphate. These findings indicate that F2 may act as a calcium antagonist, which could account for its cardiovascular benefits.

UI MeSH Term Description Entries
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D015544 Inositol 1,4,5-Trisphosphate Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. 1,4,5-InsP3,Inositol 1,4,5-Triphosphate,Myo-Inositol 1,4,5-Trisphosphate,1,4,5-IP3,Myoinositol 1,4,5-Triphosphate
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
August 2003, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
March 2013, Acta Cardiologica Sinica,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
January 2012, Biological & pharmaceutical bulletin,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
April 2015, Phytotherapy research : PTR,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
October 2005, Sheng li xue bao : [Acta physiologica Sinica],
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
January 1996, Research communications in molecular pathology and pharmacology,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
March 2016, Phytotherapy research : PTR,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
November 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Zhanqin Huang, and Ganggang Shi, and Fenfei Gao, and Yanmei Zhang, and Xingping Liu, and Theodore A Christopher, and Bernard Lopez, and Xinliang Ma
June 2006, Acta biochimica et biophysica Sinica,
Copied contents to your clipboard!